Jelmyto
Term · Oncology and biomedicine · MLC-T-ONC-004580
A drug that contains the active ingredient mitomycin, which comes from the bacterium Streptomyces, and is used to treat adults with a certain type of urothelial cancer. It is given as a solution through a catheter that is placed into the ureter or kidney. Jelmyto damages the cell’s DNA and may kill cancer cells. It is a type of antineoplastic antibiotic and a type of alkylating agent.
| Identifier | MLC-T-ONC-004580 |
|---|---|
| Field | Oncology and biomedicine |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-004580",
"term": "Jelmyto",
"field": "Oncology and biomedicine",
"definition": "A drug that contains the active ingredient mitomycin, which comes from the bacterium Streptomyces, and is used to treat adults with a certain type of urothelial cancer. It is given as a solution through a catheter that is placed into the ureter or kidney. Jelmyto damages the cell’s DNA and may kill cancer cells. It is a type of antineoplastic antibiotic and a type of alkylating agent.",
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/jelmyto/"
}
Record 9,689 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.